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CHAPTERl.GENERALINTRODUCTION 
This dissertation contains four chapters and follows the manuscript-based format. The 
first chapter is general introduction describing the background of fructose-1,6-bisphosphatase 
(D-fructose-1,6-bisphosphate 1-phosphohydrolase, FBPase, EC 3.1.3.11) including a 
literature review and a brief overview of the research problem and ideas that led to this work. 
Chapter two is the paper published in a peer-reviewed journal of which I am the co-author. 
Chapter three is a co-authored manuscript being submitted to a peer-reviewed journal for 
publication. Both these chapters deal with mutations in FBPase that give insight to the 
structural basis for allostery. The mutants used in this study were made and characterized and 
the crystallization data collected by Dr. Cristina Iancu or Dr. Jun-Yong Choe, former graduate 
students of Prof. Richard Honzatko. Prof. Honzatko and myself are responsible for the 
structural refinement and analyses leading to the results presented here and the publications. 
Chapter four summarizes the conclusions from this study and presents some ideas for future 
experiments that could lead to design of inhibitors of FBPase. 
Rationale and Experimental Approach 
The work presented in this dissertation attempts to dissect a structural basis for 
allostery in porcine FBPase. FBPase had two purported physiologic conformers: R-state, the 
active enzyme, and T-state, the inactive form (Fig.1 ). The presence of these two energetically 
stable states of FBPase gives us two distinct snapshots of the enzyme and has revealed the 
apparent functional properties of the two states supported by enzyme kinetics and 
crystallographic studies on this enzyme at physiologic pH. It can however be envisaged that 
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more low-energy conformers of FBPase could potentially exist when the enzyme transitions 
from R- to T-state or vice versa, the R- and T-states being the lowest energy forms. 
More recently, the wild-type porcine FBPase was crystallographically trapped in a 
partially active intermediate I-state in the presence of OC252, a synthesized inhibitor that 
binds at an allosteric site different from the AMP binding pocket (1). It can be hypothesized 
that the enzyme can potentially be trapped in low-energy intermediate conformers thus giving 
a series of snapshots of the enzyme in a transition from the R- to T-state. This could enable us 
to understand the mechanics of this R- to T-state transition. FBPase is a good model system for 
this study because much is known about its biochemical and functional properties from the 
extensive kinetics and existing structural database. It is a single polypeptide chain protein 
unlike some of the other allosteric enzymes, hemoglobin for instance, and thus makes for a 
simpler system to study allosteric regulation and cooperativity. This investigation of allosteric 
mechanism will also help improve our understanding of the basic biochemical processes. 
FBPase is also a key regulatory enzyme of glucose production and has been implicated in type 
II (non-insulin dependent) diabetes. Knowledge gained from this study has the future potential 
for development of effective inhibitors. It is thus essential that we thoroughly understand the 
molecular mechanisms responsible for the regulation of this enzyme. Hence, understanding 
the structural basis for transition from R- to T-state could identify a key switch/loci that shuts 
FBPase off, thereby enabling the design of inhibitory allosteric ligands that relieve 
hyperglycemia, a marked trait of type II diabetes leading to retinopathy and nephropathy (2). 
Understanding the mechanism ofFBPase, that is sequencing the conformational events 
along the pathway from the R- to T-state, can establish a structural basis for allostery and 
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cooperativity as observed by the kinetics studies. Moreover, event sequencing in the R- to 
T-state transition could identify structural loci beyond the known binding pockets for substrate 
(fructose 1,6-bisphosphate) and allosteric effector (AMP) that could serve as targets for the 
design of highly efficient inhibitors. These inhibitors would act synergistically with AMP by 
acting independently on the allosteric pathway so as to reinforce the effect of the natural 
allosteric effector. 
Alternatively, one could conceive of ligands that trap an intermediate conformational 
state of FBPase, such as has been observed for the allosteric effector OC252. In order to 
efficiently screen for ligands that recognize intermediate states of FBPase, however, one must 
necessarily create targets that are locked into such intermediate states. One could in principle 
create such targets through specific mutations that trap intermediate states. Earlier studies on 
FBPase have revealed many structural loci through potential mutations that change the 
properties of the enzyme with respect to AMP inhibition and activity. The mutation A54L, for 
instance, revealed yet another intermediate state of FBPase, an R-like conformer with AMP 
bound designated as the IR-state (3). (The earlier I-state, which is a T-like conformer with 
OC252 bound, will be referred to hereafter as the Ir-state). The mutation 11 OD revealed an 
intermediate state in the presence of AMP that closely resembles the IT-state of the 
OC252-bound wild-type enzyme. 
In general, investigations of FBPase employ standard techniques in current-day studies 
of macromolecular structure and function. Mutant forms of FBPase are made by site-directed 
mutagenesis. Enzyme is over-expressed in Escherichia coli and purified to homogeneity. 
Kinetics investigations provide rate constants, Km values for fructose 1,6-bisphosphate (Fl 6P2) 
and inhibition constants for AMP and the physiologically dynamic inhibitor fructose 
R-state 
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I-state 
FBP: fructose 1,6-bisphosphate 
AMP: adenosine monophosphate 
OC252: allosteric inhibitor 
Figure 1. Quarternary states of FBPase. 
T-state 
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2,6-bisphosphate (F26P2). Crystals of FBPase are grown by the hanging-drop vapor-diffusion 
method and x-ray data collection employs either a Rigaku R-AXIS IV++ system with confocal 
optics, or various synchrotron sources. Diffraction data are integrated and reduced using 
standard software packages (HKL and d*TREK). Structure determinations generally employ 
the molecular replacement approach. Structures are refined using CNS and all analysis is done 
with the help of programs in the CCP4 suite (such as LSQKAB) and with XtalView. 
Structures are deposited to the RCSB-PDB database. 
Analysis of x-ray structures employed the superposition of two structures as 
rigid-bodies to reveal tertiary conformation changes in the subunit. By the superposition of a 
subunit from the R-state onto the subunits of the T-state ofFBPase, one can see changes in 
conformation within the subunit and determine how these changes influence interactions 
between subunits of the tetramer. The central complication is the wealth of conformational 
change allows for too many pathways, or sequences of conformational change, in connecting 
the R- and T-states of the enzyme. Hence, the need for intermediate structures ofFBPase, 
which capture, for instance, just the effects of AMP binding to the R-state without the 
transition to the T-state, so that one can understand conformational change triggered by AMP 
and those connected with the allosteric transition which follow AMP binding. 
The program used to analyze conformational differences in structure is LSQKAB, a 
least squares program written by Kabsch that minimizes the distance between corresponding 
sets of atoms using the Lagrangian interpolation method ( 4). In simple terms, the Lagrange 
interpolation method mathematically defines the shortest path to move from point A to point B 
touching a pre-defined arc. The output from LSQKAB is a translation vector and a rotation 
matrix that when applied to one structure (called the probe structure) brings it into 
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superposition with another structure (called the target structure). The process gives 
root-mean-square deviations between specific atom types such as the Ca atoms of 
corresponding amino acid residues. It was possible by this method to define a set of residues 
that have the same relative positions in the probe and target molecules; the superpositions 
using this subset of residues removes differences in conformation due to rigid-body motions, 
leaving changes at the tertiary level, some of which can be large (up to 36 A), but many of 
which can be significant at displacements of 0.5 A or less. The quaternary conformational 
changes in FBPase are essentially rigid-body motions of subunits; the rotation of one pair of 
subunits relative to the other pair of subunits of the FBPase homotetramer through an angle of 
approximately 15°. The value for this rotation angle comes from an analysis of the LSQKAB 
rotation matrix. 
Review of Literature 
Discovered by Gomori in 1943, FBPase was described as a phosphatase having high 
affinity for hexose bisphosphate and requires Mg2+ for activity (5). FBPase, a gluconeogenic 
enzyme, is a key regulator of glucose flux acting in concert with phosphofructokinase-2/ 
fructose-1,6-bisphosphatase-2 (PFK-2/FBPase-2) in glycolysis and the hormones insulin and 
glucagon. Gluconeogenesis is the synthesis of glucose from pyruvate, lactate, triacylglycerols, 
oxaloacetate, and some aminoacids, and is reverse of glycolysis in its net effect on intracellular 
glucose levels (6). FBPase catalyzes the following reaction: Fructose-1,6-bisphosphate (F16) 
+ H20 = Fructose-6-phosphate (F6P) + inorganic phosphate (Pi) (7-8). FBPase is mainly 
present in liver, kidney, brain and skeletal muscle in mammals (7-9). 
The main source of energy in mammalian cells is glucose, and it is the only source in 
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brain under regular physiological conditions (10). The levels of glucose in the blood is very 
important in mammalian physiology. Hypoglycemia, for instance, could lead to irreversible 
brain damage (9). Mammalian liver and kidney are responsible for the regulated breakdown 
and synthesis of glucose. The tight regulation of glycolysis and gluconeogenesis avoids the 
wasteful hydrolysis of ATP in futile cycling (11). Glucose metabolism is regulated at several 
levels involving hormones, metabolites and specific enzymes (12). Glucagon and insulin are 
the primary hormones that regulate glycolysis and gluconeogenesis modulating levels of cyclic 
AMP (cAMP) depending on whether serum glucose levels are high or low (12-14). At low 
levels of serum glucose, glucagon induces the generation of cAMP. Rising levels of cAMP 
activate a cAMP-dependent protein kinase, which is one amongst other enzymes in liver that 
phosphorylates PFK-2/FBPase-2. In the phosphorylated state, the latter enzyme acts as a 
2-phosphatase on fructose-2,6-bisphosphate (F26P2), leading to decreased intracellular levels 
of this dynamic metabolite (15). As F26P2 is an activator of glycolysis (by binding to 
6-phosphofructose-1-kinase) and an inhibitor of gluconeogenesis (by binding to FBPase) ( 16), 
a reduction in F26P2 levels results in the stimulation of glucose synthesis. The opposite 
happens if serum glucose levels are high. Insulin, after a time-lag that depends on the levels of 
stored glycogen in liver cells, triggers a cascade that results in the production of F26P2 from 
fructose 6-phosphate (F6P) and ATP. F26P2 is thus a critical dynamic regulator in glucose 
metabolism (Fig. 2). 
The discovery of inhibition of gluconeogenic FBPase by F26P2 came about through 
independent studies by Pilkis as well as Van Shaftingen and Hers (17-18). It was initially 
thought that F26P2 competitively inhibits FBPase with respect to the product Fl6P2 by binding 
to an allosteric site (19-21). Distance measurement studies using NMR, however, suggested 
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that F26P2 must inhibit at the product site (22). This controversy was resolved by 
high-resolution crystal structures showing F26P2 to be present at the product site (23). AMP is 
a non-competitive inhibitor of FBPase with respect to substrate and exhibits cooperativity in 
binding and inhibition (24-25). AMP and F26P2 are synergistic in their inhibition of FBPase; 
the presence ofF26P2 makes AMP a more potent inhibitor (18,26). AMP levels in vivo are 
constant due to adenylate kinase (27). Thus varying concentrations of F26P2 in the cell 
modulate AMP inhibition. FBPase requires divalent cations for activity (5). Mg2+, Mn2+, or 
Zn2+ have been shown to bind FBPase (5,25,28). Zn2+ (45) and Mn2+ (unpublished 
observsations) bind to three metal sites, but one of three metal site (called metal site three) 
shows only partial occupancy in the presence of Mg2+ (32,45). Enzyme activity increases 
cooperatively in response to increasing concentrations of Mg2+ (Hill coefficient of 
approximately 2). Monovalent cations like K+, Rb+, Tl+ enhance enzyme activity in the 
presence of Mg2+ (29-31). 
In 1989, William Lipscomb and colleagues reported the first crystal structure of 
FBPase (34). The enzyme was confirmed to be a homotetramer with D2 symmetry and having 
C l-C2 and C l-C4 subunit interfaces (Fig. 1 ). Two different quaternary conformations of the 
enzyme were observed. The inactive T-state conformer is produced when FBPase is ligated 
with AMP and the active R-state appears in the absence of AMP with or without the active site 
ligands, F6P and F26P2 (35). The quaternary transition from the R-state to the T-state is 
basically the rotation of approximately 15° of the C 1-C2 dimer relative to the C3-C4 dimer 
about the vertical symmetry axis of the tetramer. Each subunit has an active site domain and 
allosteric AMP site domain. The AMP site is no closer than 30 A from any of the active sites 
of the tetramer. 
9 
Epinephrine Glucagon 
+ Adenylyl cyclase + l~Q7.i :~:" 
p-Adrenergic ATP cAMP AMP 
Insulin 
receptor 
Insulin 
+ 
receptor ~ :----i:::--------------? ~ 
''a • ......... 
ATP cAMP dependent ADP · ..... 
otein kinase ··· .........  \ 
Glucose 
t 
AXTF6P)p' F6P- 2- kinase a/ 
F~- 1- kinase FBPase 
+ \ ADP "'\ \ F16P - ··· .. , \ ,2 ' 
·•··... ..........---~------·---
··...... Pyruvate /~ 
'~-........ ________ . ____ ~·· 
Figure 2. Regulation of Gluconeogenesis and Glycolysis 
....... 
\ 
\ 
l 
J 
/ 
+ _....,..../ 
~--
10 
Initial crystallographic studies of FBPase left the issue of AMP allostery unresolved. 
Zhang et. al. (36) proposed two possible modes of allosteric communication within the enzyme 
upon AMP binding. The first mode of relay depends on communication after AMP binding 
from C l-C2 interface to the C l-C4 interface. The second mode is the exact opposite i.e., 
C l-C4 interacts first and a propagation via large side-chains to C l-C2. Both these modes 
would display a sequential model of transition and cooperativity in AMP binding. The other 
alternative suggested here is the concerted model involving Cl-C2 and Cl-C4 interfaces. 
These models do not exclude the possibility of a C l-C3 interaction limited to the T-state. The 
models of Zhang lack specificity and would apply to any homotetramer with an allosteric 
mechanism. 
Site-directed mutagenesis studies on FBPase have indicated numerous important 
residues playing roles in catalysis or cooperativity. D74, E98, R276, E280, E97, Dl 18 and 
Dl21 have emerged as residues necessary for catalysis (38-42). Of these E97, Dl 18, Dl21, 
and E280 coordinate to one or more of the three active site metals, R276 binds to the 
1-phosphoryl group of the substrate, and D74 and E98 coordinate to strategically positioned 
water molecules in the active site, that in tum coordinate the active-site metals. Single 
mutations at R22, K46, E192, and K50 eliminate cooperativity in AMP inhibition (33,37,47). 
K46, El93, and K50 cluster near the center of the tetramer, whereas R22 is at the outer edge of 
the tetramer near the AMP binding site. All residues are at the interface between subunits Cl 
and C4 (equivalent by symmetry to the C2-C3 interface). Other mutations (for instance, 
D 187 A) of residues nearby had no effect on AMP cooperativity ( 43). K50M had no effect on 
AMP cooperativity, but K50A and K50Q mutants lacked AMP cooperativity, having a high Kct 
for AMP ( 44). The kinetics of inhibition of AMP with respect to Mg2+ is competitive for the 
I 
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wild-type enzyme, but non-competitive with respect to substrate Fl6P2. 
The Lipscomb structures showed a lot, but there were some crucial elements missing 
due to the absence of density, in particular the residues 52-72 were absent from early structures. 
(Residues 52-72 are now called the dynamic loop of FBPase, and exist in several 
conformational states, differing by as much as 36 A in the positions of corresponding atoms). 
Residues 52-72 are highly conserved. Lipscomb had suggested that helices Hl-H3 might be 
important for the allostery (36), but with the residues 52-72 absent, there was no clear 
connection between active site and allosteric effector site. (The allosteric effector site lies 
between helices Hl and H2, whereas residues 52-72 lie between helices H2 and H3). In 1998, 
Choe et al. (45) solved a new R-state structure in the presence ofF6P, Pi and Zn2+. This 
structure revealed residues 52-72 as a loop that stabilized three Zn2+ cations in the active site 
along with F6P and Pi. This conformation of the loop was called the "engaged" conformation, 
distinguishing it from its conformation in the presence of AMP, which was called 
"disengaged". Several residues of the loop take part in important interactions with the active 
site. N64 and E98 were hydrogen bonded. Mutations of E98 inactivated the enzyme (45, 39). 
D68 co-ordinated Zn2+ at metal site 3 and hydrogen bonded with R276 (45, 40). 
Choe et al. ( 45) purported a new model of allosteric regulation of catalysis. The 
binding of AMP to the allosteric site and the subsequent R- to T-state transition, caused 
relatively small movements in helices H 1 and H2, the result of which was the displacement of 
loop 52-72 from its engaged conformation to its disengaged conformation. The loss of the 
loop-engaged conformation lowers metal affinity for the active site, and is largely responsible 
for the observation of competition in kinetics between AMP and active-site metals. 
Scott Nelson from our group tried to substantiate the dynamic loop hypothesis of Jun 
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Yong Choe. FBPase has no tryptophan. Scott used tryptophan fluorescence as a probe to 
study the dynamics of the loop 52-72 (46). The mutation Y57W in the loop showed increased 
intensity in the R-state, which has the engaged loop, and a decreased intensity in the T-state 
with the disengaged loop. The fluorescence also decreased with increasing AMP 
concentrations. This study also suggested the presence of other possible conformers of 
FBPase apart from R- and T-states due to the differing fluorescence intensities from the Zn2+, 
Mn2+ or Mg2+ complexes with products or F26P2• In an ensuing study, the most interesting 
results were obtained from the K50P mutation, which had complete loss of allosteric inhibition 
( 4 7). Positions 50 and 51 represent the hinge regions of the dynamic loop (residues 52-72), 
and mutations that impair backbone flexibility here affect the functionality of the enzyme. 
Non-proline mutations at position 50, however, had little effect on function, the enzyme 
retaining its sensitivity toward AMP. Evidently, the pro line mutations of hinge region 
prevented loop 52-72 from establishing either an engaged or disengaged conformation. 
The significance of the highly conserved N-terminal residues and their role in 
functionality was also unclear from early studies (36, 48). Crystal structures have the 
N-terminal segment (residues 1-10) either missing or in different conformations in the R- and 
T-state complexes. The deletion of the first seven N-terminal residues resulted in reduced 
catalysis and Mg2+-affinity. Deletion of the first ten residues resulted in dramatic loss of 
activity, reduced Mg2+-affinity, the complete loss ofMg2+ cooperativity and potent, but 
incomplete, inhibition of catalysis by AMP. The mutation of IlOD, however, retained 
wild-type properties except for potent, but incomplete inhibition of catalysis by AMP. The 
IlOD mutant FBPase retained 30-40% of its maximal activity in the presence of saturating 
AMP. The hydrophobic side-chain of 110 was seen as a critical component in the cluster of 
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hydrophobic residues that stabilized the disengaged conformation of the dynamic loop. 
Biphasic inhibition by AMP akin to that observed in the I 1 OD mutant FBPase has been seen in 
K42A, E192Q, E192A, K50N, and K50P/Y57W FBPases. 
Subunits ofFBPase were found to be in exchange (49). Rates of subunit exchange are 
sensitive to temperature and ligands. Temperatures above 30 °C limited subunit exchange. 
Active site ligands (F6P or F26P2) allowed exchange between subunit pairs of the tetramer, 
and AMP abolished all exchange phenomena (49,50). This study lead to the development of 
protocols to produce hybrid tetramers of FBPase that revealed several interesting properties in 
regard to AMP inhibition. Firstly, AMP inhibited hybrid tetramers of FBPase with but one 
functional binding site for AMP. Secondly, AMP inhibited hybrid FBPases with two 
functional binding sites for AMP. If the functional binding sites were within the same subunit 
pair, inhibition was non-cooperative, but still resulted in an R- to T-state transition. If the 
functional binding sites were in opposite subunit pairs of the tetramer, then AMP inhibition 
was cooperative, and still caused a quaternary transition. Nelson et al. (50) concluded that 
allosteric AMP inhibition of FBPase did not agree with a concerted model, which would 
require all modes of AMP inhibition that cause a quaternary transition to show cooperativity. 
This observation placed a significant constraint on models for allosteric regulation of FBPase, 
requiring them to conform to a sequential model of allosteric regulation. Moreover, the studies 
revealed multiple allosteric inhibition pathways in FBPase (Fig. 3, 50), only some of which 
involved co-operative interactions between allosteric effectors. 
As stated earlier, our group recently identified a new intermediate state of wild type 
porcine liver FBPase designated as the I-state (1). This state also identified a new allosteric 
site in the center of the enzyme, recognized by a pseudo-tetrapeptide inhibitor designated 
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OC252-324 (hereafter, OC252). Loop 52-72 in this complex was disengaged and subunit pair 
rotation was approximately 12°. The inhibition by OC252 is co-operative and synergistic with 
AMP and F26P2. OC252 hydrogen bonds with D 187, a conserved residue. OC252 binds to a 
site recognized by another inhibitor family, the anilinoquinazolines of Pfizer Inc. (51). These 
inhibitors may prove significant as leads to pharmaceuticals that limit FBPase activity in vivo. 
The studies presented so far have tried to dissect the structural basis for allostery. The 
next two chapters presented here will define such a basis and present models for the structural 
transition from the R- to T-state due to AMP ligation. The initial changes due to AMP binding 
will be discussed as well as the structural mechanism for loop disengagement in the transition 
from the R- to T-state. These studies unveil a new R-like intermediate state ofFBPase, 
designated as the IR-state and also another T-like state resembling the I-state (now designated 
as the h-state ), but with an engaged dynamic loop. 
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CHAPTER 2. R-STATE AMP COMPLEX REVEALS INITIAL STEPS OF THE 
QUATERNARY TRANSITION OF FRUCTOSE-1,6-BISPHOSPHATASEt 
A paper published in The Journal of Biological Chemistry 
Cristina V. Iancu, Susmith Mukund, Herbert J. Fromm, and Richard B. Honzatko 1 
Abstract 
AMP transforms fructose-1,6-bisphosphatase from its active R-state to its inactive T-
state; however, the mechanism of that transformation is poorly understood. The mutation of 
Ala54 to leucine destabilizes the T-state of fructose-1,6-bisphosphatase. The mutant enzyme 
retains wild-type levels of activity, but the concentration of AMP that causes 50% inhibition 
increases 50-fold. In the absence of AMP, the Leu54 enzyme adopts an R-state conformation 
nearly identical to that of the wild-type enzyme. The mutant enzyme, however, grows in two 
crystal forms in the presence of saturating AMP. In one, the AMP-bound tetramer is in a T-
like conformation, whereas in the other, a R-like conformation. The latter reveals 
conformational changes in two helices due to the binding of AMP. Helix H 1 moves toward 
the center of the tetramer and displaces Ile10 from a hydrophobic pocket. The displacement 
oflle 10 exposes a hydrophobic surface critical to interactions that stabilize the T-state. Helix 
H2 moves away from the center of the tetramer, breaking hydrogen bonds with a buried loop 
(residues 187-195) in an adjacent subunit. The same hydrogen bonds reform, but only after 
the quaternary transition to the T-state. Proposed here is a model that accounts for the 
quaternary transition and cooperativity in the inhibition of catalysis by AMP. 
This work was supported in part by National Institutes of Health Research Grant NS 10546. 
tcoordinates and structure factors (accession labels 1 YXI, 1 YYZ and 1 YZO) for the 
structures described in this paper have been deposited in the Protein Data Bank, Research 
Collaboratory for Structural Bioinformatics (RCSB). 
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Introduction 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 
3.1.3.11; FBPase1) catalyzes a tightly regulated step of gluconeogenesis, the hydrolysis of 
fructose 1,6-bisphosphate (Fl6P2) to fructose 6-phosphate (F6P) and inorganic phosphate (Pi) 
(1,2). AMP and fructose 2,6-bisphosphate (F26P2), binding to allosteric and active sites, 
respectively, inhibit FBPase while simultaneously activating its counterpart in glycolysis, 
fructose-6-phosphate 1-kinase (3,4). Biosynthesis and degradation of F26P2 is subject to 
hormonal control principally by glucagon and insulin ( 4,5). F26P2 enhances the binding of 
AMP to FBPase by up to an order of magnitude ( 6). Hence, although intracellular 
concentrations of AMP remain relatively constant, AMP should become a more potent 
inhibitor of FBPase as concentrations of F26P2 increase. AMP binds 28 A away from the 
nearest active site, and perhaps not surprisingly inhibits catalysis noncompetitively with 
respect to F16P2• Yet, AMP is a competitive inhibitor of catalysis with respect to essential 
divalent cations (Mg2+, Mn2+, or Zn2+), all of which are in proximity to (and probably 
coordinate with) the 1-phosphoryl group ofF16P2 (7-10). 
FBPase is a homotetramer [subunit Mr of 37,000 (11)] and exists in at least two 
distinct quaternary conformations called Rand T (12-13). AMP induces the transition from 
the active R-state to the inactive (or less active) T-state. Substrates or products in 
combination with metal cations stabilize the R-state conformation. A proposed mechanism 
for allosteric regulation of catalysis involves three conformational states of loop 52-72 called 
engaged, disengaged, and disordered ( 14 ). AMP alone or with F26P2, stabilizes a disengaged 
loop (15,16), whereas metals with products stabilize an engaged loop (10,16-18). In active 
forms of the enzyme, loop 52-72 probably cycles between its engaged and disordered 
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conformations (14,17). Fluorescence from a tryptophan reporter group at position 57 is 
consistent with the conformational states for loop 52-72, observed in crystal structures 
(19,20). Thus far, the engaged conformation ofloop 52-72 has appeared only in R-state 
crystal structures, and the disengaged conformer only in T-state structures; however, 
disordered conformations of the dynamic loop have appeared in both the R- and T-states 
(16,17,21,22). 
The precise sequence of events that attend the R- to T-state transition in FBPase has 
been elusive. Crystal structures of the R- and T-states are the endpoints of the allosteric 
transition, and leave much to speculation regarding intermediate conformational states of 
FBPase. The immediate consequences of AMP binding to the R-state are unknown. Does 
the dynamic loop become disengaged in response to the binding of AMP or in response to the 
allosteric transition to the T-state? How does the binding of AMP destabilize the R-state and 
stabilize the T-state? A recent study revealed the first intermediate state of porcine FBPase 
(23), a T-like conformation due to the binding of an allosteric effector to the center of the 
tetramer. The results of that study indicated the potential for trapping intermediate 
conformational states of FBPase by crystallization. 
The mutation of Ala54 to leucine disrupts key packing interactions of the disengaged 
loop conformation. The resulting Leu54 enzyme has wild-type catalytic properties and retains 
cooperativity in AMP inhibition, but exhibits a 50-fold increase in the IC5o for AMP. In the 
absence of AMP, Leu54 FBPase is in its canonical R-state. Two crystal forms, however, 
grow in the presence of saturating AMP. In one crystal form, the enzyme is in its T-state, but 
with a disordered dynamic loop. In the other crystal form, the tetramer is in an R-like 
quaternary state with an engaged dynamic loop. The latter crystal form reveals the 
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immediate consequences of AMP association in the absence of an allosteric transition. The 
observed conformational changes suggest the mechanism by which AMP leverages the 
allosteric transition in FBPase. 
Experimental 
Materials-Fl6P2, F26P2, NADP+ and AMP were purchased from Sigma. DNA-modifying 
and restriction enzymes, T4 polynucleotide kinase and ligase were from Promega. Glucose-
6-phophate dehydrogenase and phosphoglucose isomerase came from Roche. Other 
chemicals were of reagent grade or equivalent. Escherichia coli strains BMH 71-18 mutS 
and XLl-Blue came from Clontech and Stratagene, respectively. The FBPase-deficient E. 
coli strain DF 657 came from the Genetic Stock Center at Yale University. 
Mutagenesis of wild-type FBPase- The mutation of Ala54 to leucine was accomplished by 
specific base changes in a double-stranded plasmid containing the gene coding for FBPase 
using the Transformer™ site-Directed Mutagenesis kit (Clontech). The mutagenic primer for 
Ala54~Leu was 5'GGCGGGCATCCTGCACCTC3'. (The codon with the point mutation is 
underlined in bold typeface). The selection primer for mutagenesis, 
5'CAGCCTCGCCTCGAGAACGCCA3' (digestion site underlined in bold typeface), 
changed an original Nrul site on the plasmid into a Xhol site. The mutation and the integrity 
of the construct were confirmed by sequencing the promoter region and the entire open 
reading frame. The Iowa State University sequencing facility provided DNA sequences, 
using the fluorescent dye-dideoxy terminator method. 
Expression and Purification of wild-type and Leu54 FBPases-Cell-free extracts ofwild-
type and Leu54 FBPases were subjected to heat treatment (63° C for 7 minutes), followed by 
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centrifugation. The supernatant solution was loaded onto a Cibracon Blue sepharose column, 
previously equilibrated with 20 mM Tris-HCl, pH 7.5. The column was washed first with 20 
mM Tris-HCl, pH 7.5. Enzyme was eluted with a solution of 500 mM NaCl and 20 mM 
Tris-HCl of the same pH. After pressure concentration (Amicon PM-30 membrane) and 
dialysis against 10 mM Tris-HCl, pH 8.0, the protein sample was loaded onto a DEAE 
sepharose column equilibrated with 10 mM Tris-HCl, pH 8.0. Purified enzyme was eluted 
with a NaCl gradient (0-0.5 M) in 10 mM Tris-HCl, pH 8.0, and then dialyzed extensively 
against 50 mM Hepes, pH 7.4, for kinetic investigations and for crystallization experiments. 
Purity and protein concentrations ofFBPase preparations were confirmed by SDS-
polyacrylamide gel electrophoresis (25) and the Bradford assay (26), respectively. 
Kinetic experiments- Assays for the determination of kcat, and specific activity ratios at pH 
7.5/9.5 employed the coupling enzymes, phosphoglucose isomerase and glucose-6-phosphate 
dehydrogenase (1). The reduction ofNADP+ to NADPH was monitored by absorbance at 
340 nm. All other assays used the same coupling enzymes, but monitored the formation of 
NADPH by its fluorescence emission at 470 nm, using an excitation wavelength of 340 nm. 
Assays were performed at 22 °C in 50 mM Hepes, pH 7.5, or in 50 mM Caps, pH 9.5. Assay 
solutions contained ethylenediamine tetracetic acid (EDT A) and KCl at concentrations of 10 
µMand 150 mM, respectively. Initial rates were analyzed with programs written either in 
MINITAB, using an a value of2.0 (26), or by ENZFITTER (27). The kinetic data for AMP 
inhibition with respect to Mg2+ and F26P2 inhibition with respect to Fl 6P2 were fit to several 
models, but only parameters associated with the best fitting mechanism of inhibition are 
reported in the results section. 
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Crystallization of the product complex- Crystals of Leu54 PB Pase were grown by the 
method of hanging drops. Equal parts of a protein solution and a precipitant solution were 
combined in a droplet of 4 µL total volume. Wells contained 500 µL of the precipitant 
solution. R-state crystals grew from a protein solution [Leu54 FBPase (10 mg/ml), Hepes (25 
mM, pH 7.4), MgCh (5 mM), and Fl6P2 (5 mM)] combined with a precipitant solution 
[Hepes (100 mM, pH 7.4), polyethylene glycol 3350 (8% (w/v)), glycerol (27% (v/v)), and t-
butanol (5% (v/v))]. Crystals of the R-like AMP complex grew from a protein solution 
[Leu54 FBPase (10 mg/ml), Hepes (25 mM, pH 7.4), MgCh (5 mM), F16P2 (5 mM), and 
AMP (5mM)] combined with a precipitant solution [Hepes (100 mM, pH 7.4), polyethylene 
glycol 3350 (12% (w/v)), glycerol (23% (v/v)), and t-butanol (5% (v/v))]. Crystals of the T-
state AMP complex grew from a protein solution [Leu54 FBPase (10 mg/ml), Hepes (25 mM, 
pH 7.4), MgCh (5 mM), F16P2 (5 mM), and AMP (5 mM)] combined with a precipitant 
solution [Hepes (100 mM, pH 7.4), polyethylene glycol 3350 (14% (w/v)), 2-methyl-2,4-
pentanediol (21 % (v/v)), and t-butanol (5% (v/v))]. Crystals were of equal dimensions (0.2-
0.4 mm), growing in approximately three days at 20 °C. Conditions of crystallization include 
cryoprotectants; crystals can be transferred directly from droplet to liquid nitrogen. 
Data collection- Data were collected at Iowa State University from single crystals on a 
Rigaku R-AXIS IV++ rotating anode/image plate system, using CuKa radiation from an 
Osmic confocal optics system, and a temperature of 110 K. Data were reduced with the 
program package CrystalClear, provided with the instrument. 
Structure determination, model building and refinement- Crystals of Leu54 PB Pase are 
isomorphous to either the AMP/Zn2+/product complex (16) or the Zn2+/product complex (10). 
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Phase angles, used in the generation of initial electron density maps, were based on model 
lEYJ or lCNQ of the PDB, from which water molecules, metal cations, small-molecule 
ligands, and residues 52-72 had been omitted. Residues 52-72 were built into the electron 
density of omit maps, using the program XTAL VIEW (28). Ligands were added to account 
for omit electron density at the active site and/or the AMP site. The resulting models 
underwent refinement, using CNS (29) with force constants and parameters of 
stereochemistry from Engh & Huber (30). A cycle of refinement consisted of slow cooling 
from 1000-300 Kin steps of 25 K, followed by 120 cycles of conjugate gradient 
minimization, and concluded by the refinement of individual thermal parameters. Thermal 
parameter refinement employed restraints of 1.5 A.2 on nearest neighbor and next-to-nearest 
neighbor main chain atoms, 2.0 A.2 on nearest neighbor side chain atoms, and 2.5 A.2 on next-
to-nearest neighbor side chain atoms. 
In subsequent cycles of refinement, water molecules were fit to difference electron 
density of 2.5cr or better and were added until no significant decrease was evident in the Rfree 
value. Water molecules in the final models make suitable donor-acceptor distances to each 
other and the protein and have thermal parameters under 60 A 2• Stereochemistry of the 
models was examined by the use of PROCHECK (31 ). 
Results 
Rationale for the Leu54 ~ Ala mutation- The C~ atom of Ala54 is at the center of a cluster of 
hydrophobic side chains, which forms only when the dynamic loop is in its T-state 
disengaged conformation. A mutation at position 54 to a large side chain should disrupt 
packing interactions and thereby destabilize the disengaged conformation of the dynamic 
loop. In contrast, ample room is available for large side chains at position 54 in the R-state 
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engaged conformation of the loop. The Ala54~ Leu mutation then should shift the 
equilibrium population of AMP complexes ofFBPase toward the R-state. 
Expression and purification of wild-type and Leu54 FBPases-Expression and isolation 
procedures described above provide wild-type and Leu54 FBPases in at least 95% purity, as 
judged by SDS-polyacryamide gel electrophoresis (data not shown). Gels indicated no 
proteolysis of the purified enzymes. 
Kinetics Experiments- Kinetics parameters for Leu54 and wild-type FBPases are in Table I. 
The determination of kcat and Km for Fl6P2 (listed as KmFI 6P2 in Table I) at pH 7.5 employed a 
saturating concentration ofMg2+ (2 mM for Leu54 FBPase and 5 mM for wild-type FBPase) 
and concentrations of substrate ranging from 0.5-20 µM. A fit of the Michaelis-Menten 
equation to the data provided values for kcat and KmFI 6P2 (Michaelis constant for F26P2). 
Ratios of specific activities at pH 7.5 to 9.5 for wild-type and Leu54 FBPases (each above 3) 
are indicative of tetrameric enzymes with intact (non-proteolyzed) polypeptide chains. 
The Hill coefficient for Mg2+ was determined at a saturating concentration of Fl 6P2 
(20 µM) and concentrations of free Mg2+ ranging from 0.1-5.0 mM. Data were fit to Eq 1: 
v!Vm = 11[1 + (Ao.s/ArJ Eq. 1 
where vis the velocity, Vm is the maximum velocity at saturating concentrations ofFl6P2 
and Mg2+, A is the concentration of Mg2+, n is the Hill coefficient for Mg2+, and Ao.sis the 
concentration ofMg2+ that gives v!Vm of one-half. 
The Hill coefficient for AMP was determined at saturating F 16P2 (20 µM), Mg2+ 
concentrations of 0.8 and 0.15 mM for wild-type and Leu54 FBPases, and AMP 
concentrations ranging from 0-500 µM. Data were fit to Eq. 2: 
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v!Vo = 11[1 + (Illo.sY] Eq. 2 
where vis the velocity, Vo is the velocity at an AMP concentration of zero, I is the 
concentration of AMP, n is the Hill coefficient for AMP, and 10.5 is the concentration of AMP 
that gives v!Vo of one-half. 
The kinetic mechanism of AMP inhibition with respect to Mg2+ was determined from 
assays that employed saturating (20 µM) F 16P2, five different Mg2+ concentrations ranging 
from 0.8-3.0 mM for wild-type enzyme or 0.2-0.6 mM for Leu54 FBPase, and five different 
AMP concentrations ranging from 0-150 µM. A model for linear competitive inhibition (Eq. 
3) provided the best result (goodness-of-fit ofless than 4%): 
Vmlv = 1 + Ka!A 2+ (Ka!K(MP) (J/A)2 Eq. 3 
where vis the velocity, Vm is the velocity at an inhibitor concentration of zero, saturating 
concentrations ofF16P2 and Mg2+, A is the concentration ofMg2+, I the concentration of 
AMP, Ka the Michaelis constant for Mg2+, and Ki AMP the dissociation constant for AMP from 
the enzyme-inhibitor complex. Eq. 3 constrains the Hill coefficients for Mg2+ and AMP to 2, 
consistent with independent determinations of these quantities. 
The kinetic mechanism of F26P2 inhibition with respect to F 16P2 was determined 
from assays that employed saturating Mg2+ (5 mM for wild-type enzyme and 2 mM for Leu54 
FBPase ), five different concentrations ( 1-6 µM) of Fl 6P2, and five different concentrations 
(0-1.0 µM ) of F26P2. A model for linear competitive inhibition provided the best fit to the 
data (goodness-of-fit ofless than 3%): 
V mlv = 1 + Kb/ B+ (Kb! Kt26P2) (JIB) Eq. 4 
where V m is the velocity at an inhibitor concentration of zero and saturating concentrations of 
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F 16P2 and Mg2+, B is the concentration of F 16P2, I the concentration of F26P2, Kb the 
Michaelis constant for F 16P2, and Kt26P2 the dissociation constant for F26P2 from the 
inhibitor enzyme-complex 
Product complex of Leu54 FBPase (PDB identifier 1 YXI)-Crystals belong to the space 
group 1222 (a=52.8, b=82.8 and c=165.5 A), and are isomorphous to those of wild-type 
FBPase in its R-state, containing one subunit of the tetramer in the asymmetric unit of the 
crystal ( 10, 16-18). Electron density for residues 1-6 is weak or absent; the model begins at 
residue 7 and continues to the last residue of the sequence. Thermal parameters vary from 10 
to 70 A 2• The model has stereochemistry (as determined by PROCHECK (31)) comparable 
to that of structures of equivalent resolution. Statistics for data collection and refinement are 
in Table II. 
The product complex of Leu54 FBPase is identical to that of the wild-type enzyme 
save clear electron density showing the leucyl side chain at position 54. One molecule each 
ofF6P and Pi bind to the active site with three atoms ofMg2+. The dynamic loop (residues 
52-72) is in its engaged conformation. Superposition of the Leu54 subunit onto the wild-type 
subunit reveals no deviation in the relative positions of Ca atoms in excess of 0.43 A. 
Superposition of the Leu54 tetramer onto canonical wild-type R- and T-states clearly indicates 
an R-state complex. We refer the reader to other descriptions of R-state product complexes 
(10, 16-18) for more detailed descriptions of comparable structures. 
AMP/product R-like complex of Leu54 FBPase (PDB identifier 1 YYZ)- Crystals belong to 
the space group 1222 (a=53.8, b=82.6 and c=166.6 A). They contain one subunit in the 
asymmetric unit and are isomorphous to those of wild-type FBPase in its R-state (10,16-18). 
30 
Electron density for residues 1- 9 is weak or absent; the model begins at residue 10 and 
continues to the last residue of the sequence. Thermal parameters vary from 10 to 7 5 A 2• 
The model has stereochemistry comparable to that of structures of equivalent resolution (31 ). 
The subunit of the AMP/product complex ofLeu54 FBPase has one molecule each of 
F6P and Pi with two atoms of Mg2+ at the active site. In addition, strong electron density is 
present in the allosteric inhibitor pocket, which represents a bound molecule of AMP (Fig. 
1 ). The dynamic loop (residues 52-72) adopts the engaged conformation. Superposition of 
the Leu54 tetramer onto canonical wild-type R- and T-states reveals a change in quaternary 
state (Table III). Subunit pair Cl- C2 has rotated 3° relative to C3-C4 (Fig. 2). The subunit 
rotation lies between that of the canonical R-state (0° rotation) and T-state (15° rotation), and 
differs from the intermediate quaternary state (9° rotation) stabilized by the allosteric 
inhibitor OC252 (Fig. 2). Hereafter, we will use the label IR to represent the R-like state of 
the AMP/product complex of Leu54 FBPase, and h to represent the T-like state of the OC252 
complex. 
The IR structure reveals the effect of AMP binding in the absence of a complete 
quaternary transition. The superposition of the IR subunit onto the subunits of the R-state 
tetramer removes coordinate displacements due to the partial (3 °) rotation of the subunit pairs 
in the IR-state, revealing conformational changes at the tertiary level. In such a comparison, 
conformational changes are evident only in the N-terminal element and helices Hl and H2. 
The 6-amino group of AMP draws backbone carbonyl 17 (helix Hl) toward itself, while 
pushing away the side chain ofVal 17 in avoiding unacceptable nonbonded contacts (Fig. 3a). 
The interactions between AMP and Val17 translate helix Hl by 0.5 A toward the center of the 
tetramer and move C-terminal end of helix Hl approximately 1.0 A toward the bound AMP 
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molecule. The movement compresses the N-terminal end of helix Hl into residues 193-195 
of subunit Cl, and displaces the side chain oflle10 from a hydrophobic cluster of residues 
(Figs. 3b&c ). Helix H2 moves along its axis 0.5 A away from the center of the tetramer. 
Helix movements sever hydrogen bonds between Thr14 and Asn35 and between Thr39 and 
Glu192, the latter a linkage between subunits Cl and C4 (Table IV). Moreover, the hydrogen 
bond between Thr46 and backbone carbonyl 189 (another Cl-C4 contact) may be weakened. 
Lys42 remains in its inter-subunit salt link with Glu192, with little change to its other hydrogen 
bonding interactions. The loss or weakening of hydrogen bonds involving Thr39, Thr46 , and 
Glu192 observed in the IR structure is not evident in a direct comparison of the canonical R-
and T-states (Table IV). 
The superposition of the IR-state subunit onto the subunits of the T-state tetramer of 
wild-type FBPase reveals tertiary conformational change due to the 12° subunit-pair rotation. 
This includes the movement of the dynamic loop from its engaged to disengaged conformer, 
a displacement of more than 30 A for some Ca carbons of that loop. For the most part, other 
conformational changes involve modest displacements in atoms not exceeding 0.5 A. These 
changes involve almost every atom in FBPase in a correlated set of collective movements. 
Immediately evident is the additional translation of helix H2, outward from the center of the 
tetramer and along its axis, and the occurrence of unacceptable contacts between loops 190 
(Fig. 4). The unacceptable contacts are relaxed in the T-state subunit by movements in loops 
190 in subunits C 1 and C4 away from a molecular axis of twofold symmetry. 
AMP/product T-state complex of Leu54 FBPase (PDB identifier 1 YZO)-Crystals belong to 
the space group P2 1212 (a=59.7, b=l66.l and c=78.9), and are isomorphous to those of AMP 
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complexes ofFBPase (16,17). The subunit pair Cl-C2 is in the asymmetric unit of this 
crystal form. Regions of weak or absent electron density include residues 1-8 and 55-72. 
The model begins at residue 9 and continues to the last residue of the sequence, but segment 
55-72 is unreliable, as evidenced by thermal parameters as high as 113 A2• The model has 
stereochemistry generally comparable to that of structures derived from data of comparable 
resolution (31 ). Statistics for data collection and refinement are in Table II. 
The enzyme in this crystal form is in the T-state (quaternary transition angle of 15°); 
however, unlike loop-disengaged AMP complexes of the wild-type enzyme, the dynamic 
loop in T-state Leu54 FBPase is disordered. Moreover, hydrogen bonds normally well 
established in the T-state of the wild-type enzyme seem to be marginally weaker in T-state 
Leu54 FBPase. The active site retains F6P and Mg2+ bound with low occupancy to site 1. 
Discussion 
Conformational changes between the R- and IR-states of Leu54 FBPase are consistent 
with two models for quaternary change: a concerted model in which AMP drives the 
quaternary transition by acting on a set of interconnected levers and a sequential model in 
which AMP raises the energy level of the R-state while simultaneously lowering that of the 
nascent T-state (Fig. 5). The point of departure for each model is an AMP-induced 
translation of helices H 1 and H2 in opposite directions, helix H 1 toward and helix H2 away 
from the center of the tetramer. The two models differ in regard to the consequences of helix 
H2 movement. For the concerted model, helix H2 retains its interactions with loops 190, 
whereas in the sequential model, interactions between helix H2 and loops 190 are broken. 
In the concerted model, two sets of coupling interactions distribute forces throughout 
the entire tetramer due to the binding of one AMP molecule. One set of interactions involves 
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Thr39, Lys42 and Thr46 of helices H2 with Glu192 and backbone carbonyls 189 and 190 of 
loops 190 (Table IV). These interactions link subunits Cl to C4 and C2 to C3. A second set 
of interactions defines the Cl-C2 and symmetry-related C3-C4 subunit interfaces (13). The 
binding of one molecule of AMP to say subunit C 1, results in the aforementioned movements 
of helices Hl and H2. The movement in helix H2 of subunit Cl exerts an outward force on 
loops 190 of subunits Cl and C4. The Cl-C2 and C3-C4 subunit interactions, however, 
constrain loops 190 to a fixed distance from the center of the tetramer. Loops 190 can only 
follow the outward movement of helix H2 by the rigid body rotations of subunit pairs C l-C2 
and C3-C4 (Fig. 5). The two sets of coupling interactions insure that all loops 190 and their 
associated subunits undergo rigid-body motions, and that all helices H2 undergo an outward 
movement in response to the binding of one or more molecules of AMP. 
The concerted model suffers from two significant shortcomings. Firstly, the coupling 
interactions between helix H2 and loops 190 have weakened in the IR state. Only the 
interactions involving Lys42 appear unaffected by movements in helices H2, and we suggest 
below that even this critical salt link may rupture during the quaternary transition. The 
weakened linkages between helices H2 and loops 190, however, may be the consequence of 
having four AMP molecules bound to an R-state tetramer. Two bound molecules of AMP 
convert R-state hybrid tetramers ofFBPase into their T-states (32). Hence, the IR-state of the 
Leu54 FBPase may represent an "over-torqued" tetramer, the existence of which is possible 
only because the mutation at position 54 eliminates the T-state as a low-energy alternative. 
The second shortcoming of the concerted model is not so easy to dismiss. A concerted 
mechanism for FBPase requires cooperativity in the binding of AMP molecules to any pair of 
sites. A hybrid tetramer of FBPase that constrains AMP-binding to subunits C 1 and C2, 
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however, exhibits non-cooperative inhibition even though it undergoes a quaternary 
transition (32). 
In considering the sequential model for the quaternary transition, we note first that the 
subunit rotation observed in the R- to T-state transition cannot happen as a rigid-body 
motion. In the R-state, loop 190 from subunit Cl is in contact with the symmetry-related 
loop from subunit C4. Progress toward the T-state results in unacceptable contacts between 
loops 190 from subunits Cl and C4. Loop 190 must undergo conformational change, but 
multiple hydrogen bonds fix its conformation in both the R- and T-states (Table IV). The 
movement of helix H2 releases a conformational restraint on loop 190 in a neighboring 
subunit by the disruption or weakening of hydrogen bonds involving Thr39 and Thr46 . In this 
environment of fewer restraints, loop 190 is more likely to relax unfavorable contacts that 
occur during the quaternary transition. Moreover, the movement in helix H2 favorably 
positions Thr39 and Thr46 for the formation of strong hydrogen bonds in the T-state. In fact, 
the hydrogen bond involving Glu192 and Thr39, ruptured in the R- to IR-state transition, 
reforms in the T-state. The mechanism is fully reversible: loss of AMP from the T-state 
presumably causes helix H2 to move back toward the center of the enzyme, breaking or 
weakening hydrogen bonds between subunits C 1 and C4, and repositioning Thr39 and Thr46 
in favor of R-state interactions. 
The sequential model can accommodate both cooperative and non-cooperative 
mechanisms of AMP inhibition. A mixture of hybrid mutants ofFBPase that force AMP-
binding to opposite halves of the tetramer exhibits cooperative inhibition (32). Hence, 
subunit coupling must exist between top and bottom halves of the tetramer. Coupling 
interactions necessarily involve subunits Cl and C4, as subunits Cl and C3 have no direct 
35 
interactions in the R-state. The binding of AMP to subunit Cl may not only disrupt 
hydrogen bonds between helix H2 of subunit Cl and loop 190 of subunit C4, but it may also 
weaken symmetry-related hydrogen bonds between helix H2 of subunit C4 and loop 190 of 
subunit C 1. Hence, a second molecule of AMP would divert less of its binding energy to the 
movement of helix H2 in subunit C4 and, as a consequence, bind with higher affinity. All 
reported mutations ofLys42, Arg49, Glu192, Ile190, and Gly191 , and some mutations ofLys50, 
abolish AMP cooperativity (22,33-35). These residues are part of helix H2 or loop 190, and 
are near to or part of the coupling interactions between subunits Cl and C4. 
A second coupling pathway between AMP binding sites may involve Arg22 • The 
mutation of Arg22 to methionine eliminates cooperativity in AMP inhibition (36). Arg22 is 
near the AMP pocket, has high thermal parameters in the R-state, and does not participate in 
inter-subunit hydrogen bonds in either the R- or T-state structures. Replacing subunit Cl of 
R-state Leu54 FBPase with an IR subunit generates a model that approximates FBPase with 
one bound molecule of AMP (Fig. 6). In that model, Arg22 of subunit C 1, due to 
conformational changes induced by AMP, makes a strong hydrogen bond with backbone 
carbonyl 108 of subunit C4. The formation of the symmetry related hydrogen bond 
involving Arg22 of subunit C4 should induce conformational changes in subunit C4 that favor 
the binding of AMP. 
The concerted and sequential models both assume an energy barrier between R- and 
T-states. In the sequential model, hydrogen bonds involving Thr39 and Thr46 contribute 
significantly to the barrier, but not so in the concerted model as these interactions are 
retained. At least one other interaction may contribute significantly to the energy barrier 
between R- and T-states. Unacceptable contacts between the side chains of Glu 192 (subunit 
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C4) and Lys42 (subunit Cl) are likely during the quaternary transition (Fig. 4b). A 
conformational change in the side chain of Glu192 eliminates bad contacts with Lys42, and re-
establishes its hydrogen bond with Thr39 . The conformational change in Glu192 may require a 
transitory loss or weakening of its salt-link with Lys42 . The presumed loss of this salt-link 
could favor the dissociation of the tetramer into subunit pairs (Cl-C2 from C3-C4), and 
thereby represent the first step in FBPase subunit exchange kinetics (32,37). 
The models above have yet to consider conformational change in the dynamic loop 
(residues 52-72). In all reported structures of FBPase, the dynamic loop is either engaged or 
disordered in R-like states, and either disordered or disengaged in T-like states. The AMP-
induced movement of helix Hl, which probably occurs in concert with that of helix H2, 
displaces Ile10 from a hydrophobic surface. That surface interacts with side chains of the 
dynamic loop in its disengaged T-state conformation (Fig. 4c ). In the R-state then, Ile10 
effectively blocks the disengaged conformer of the dynamic loop. The formation of the 
disengaged conformer appears as a significant thermodynamic driving force in the quaternary 
transition to the T-state. A modest change in the conditions of crystallization (substitution of 
glycerol for 2-methy-2,4-pentanediol) transforms the AMP/product complex of Leu54 FBPase 
from a loop-disordered T-state to a loop-engaged R-state. Direct interactions between 
cryoprotectant and enzyme are unlikely as no bound cryoprotectant molecules appear in 
either crystal structure. The AMP/product complex of Leu54 FBPase then probably has 
substantial populations ofIR- and T-states in solution, allowing the growth of different crystal 
forms under nearly identical conditions. 
The potential significance of C 1-C4 interactions in FBPase has been suggested by 
others ( 13 ,22), but crystal structures of the R- and T-states did not reveal the transitory loss 
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of hydrogen bonds across the C 1-C4 subunit interface. As a consequence, the basis for a 
sequential mechanism of quaternary change remained hidden. The sequential model 
presented here reconciles properties of AMP inhibition in wild-type, mutant and hybrid 
FBPases with known conformational changes in the tetramer. The present study also 
suggests that AMP-ligation of the R-state does not displace the dynamic loop from its 
engaged conformation. Instead, the dynamic loop leaves the engaged conformation in the T-
state, for reasons now poorly understood. 
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1The abbreviations used are: FBPase, fructose-1 ,6-bisphosphatase; Fl6P2, fructose 1,6-
bisphosphate; F6P, fructose 6-phosphate; F26P2, fructose 2,6-bisphosphate; Pi, 
orthophosphate. 
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Table I. Kinetic parameters for wild-type and Leu54 FBPases. Parameters are defined in 
the results section. 
Wild-type Leu54~ Ala 
Activity ratio, pH 7.5:9.5 3.5±0.5 3.9±0.4 
kcat (sec- 1) 20±1 11.3±0.6 
I 
KmF16P2 (µM) 1.2±0.05 I 0.94±0.04 
I 
I -r ---
Ao.s (mM) 0.84±0.04 
I 
0.14±0.03 
,------- -- --------,--- ~±0.2 Hill coefficient Mg2+ 1.7±0.1 
-· I 
r Io.s (µM) 1.23±0.04 62±1 
I 
I ----Hill coefficient AMP 2.2±0.1 2.5±0.1 
- - - - I 0.78±0.2 Ka (mM2) 0.087±0.005 
I 
I 
KtMP (µM2) 0.6±0.1 I 3000±200 
I 
. I 
- -----
Kb (µM) 2.4±0.4 1.2±0.1 
-r--
I 
I 
Kt26P2 (µM) I 0.23±0.04 0.38±0.04 
I 
--------
42 
Table II. Statistics of data collection and refinement for Leu54 FBPase. 
Crystalline complexa 
: Resolution limit (A) 
Number of measurements 
1 Number of unique reflections 
l 
r-
I Completeness of data (%): 
lo~e~a~l -
I 
R-state IR-state T-state 
2.0 1.85 2.15 
155,545 124,926 193,057 
24,972 32,122 41,418 
--i--
---~-1 
99.6 99.1 99.2 
ILas~s:~l/r:solu~ion-range (A) ~- 96.~/2. 07-2. 0 -1 91.1/ 1.96-1.85 1 98. 6/2.25-2 ~ 
[ Rsymb - -- - -----1 I -, 
I Over:~- - - - - 0.066 -,~035--~--1 
.--------- - -
Last shell/resolution-range (A) 
Number of reflections in 
refinement 
I 
I ,---- - --
1 Number of atoms 
I 
I 
r umber of solvent s~es 
IRractor' -
--, 
0.23/2.07-2.0 I 0.21/1.96-1.85 
22,691 -i-:-9,277 
0.20/2.25-2.15 I 
37,089 
-- r --
2,7;;-12,785 ~7--1 
176 r- 29-6--1 510 -
I 0.223 ~-0.199 
I 
--------------------' 
d Rrree 
1 Mean B (A2) for protein 
I Mean B (A 2) for AMP 
Root mean square deviations 
(deg): 
I Bond lengths (A) 
I ~ond angles 
I Dihedral angles 
Improper angles 
Table II. Footnotes. 
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0.242 
30 
0.006 
1.4 
22.8 
0.78 
0.266 0.261 
20 36 
38 29/34 
--r-
0.005 0.005 
22.5 22.9 
o.75 - ,-_o_.1_2_J 
a Space group and unit cell parameters provided in the results section. 
b Rsym = LJLi I lu - <fi> I /LiL/iJ, where i runs over multiple observations of the same intensity, 
and j runs over all crystallographically unique intensities. 
c Rractor = L II Fobs I - I Fcalc II IL I Fobs 1, where I Fobs I> 0. 
ct Rrree based upon 10% of the data randomly culled and not used in the refinement. 
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Table III. Root-mean-squared deviations between conformational states of FBPase. 
RCSB identifiers lEYK and lCNQ represent the canonical T- and R-states, respectively. h 
is the T-like state of the OC252 complex ofFBPase (PDB identifier 1Q9D). IR is the R-like 
state of the AMP/product complex of Leu54 FBPase reported here. The determined angle of 
rotation is sensitive to the subset of Ca atoms used in the calculation of the rotation matrix. 
The use of all Ca atoms, including those of the dynamic loop, results in an angle of 18° for 
the R- to T-state transition. In contrast, the use of Ca atoms that deviate by less than 1 A in 
the initial superposition gives an angle of 13°. Superpositions and root-mean squared 
deviations here are based on Ca atoms from the following residues: 33-49, 75-265, and 272-
330. Values in bold typeface come from superpositions of tetramers. Other values come 
from superpositions of C 1-C2 dimers. The latter provide an estimate of coordinate 
uncertainty due to random and systematic errors. 
r - - - I --r-·- r-~ I IR h 
r .. I I R 0.30/0.74 0.48/2.16 0.58/2.7 ,- -· r -~48/2.09 I IR I I 0.43/1.54 I I 
r--1 -i----- -- ---~0.64 
I h I I I 
---- ---
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Table IV. Selected donor-acceptor distances (in A) for R-, IR- and T-states of FBPase. 
The R-state and T-state structures are from the RCSB, accession labels lCNQ and lEYK, 
respectively. The two values entered for the T-state are from the two subunits in the 
asymmetric unit. 
Donor-acceptor pair 
Intersubunit C 1-C4 
Arg22 NHl - Glu108 0 
Arg22 NE- Glu108 0 
Thr39 OGl - Glu192 OEl 
Lys42 NZ - Ile190 0 
Lys42 NZ - Gly191 0 
Lys42 NZ- Glu192 OEl 
Thr46 OGl -Ala189 0 
Intrasubunit 
Val 11 O-Leu195 N 
Leu13 N -Phe193 0 
Thr14 OGl -Asn35 ODl 
Thr14 OG 1 - Asn35 ND2 
Thr14 OGl - Glu192 OE2 
Lys42 NZ - Gly191 0 
AMP N6-Thr31 OGl 
AMP N6- Val17 0 
R-state distance IR-state distance T-state distance 
4.4 4.6 
4.1 5.7 
2.7 3.7 
3.0 3.1 
3.2 3.1 
2.9 2.7 
3.2 3.4 
3.0 2.9 
3.0 2.8 
2.5 3.5 
3.8 5.4 
5.3 4.4 
2.9 2.7 
3.5 
2.7 
9.9/10.9 
3.0/3.1 
3.1/3.1 
3.313.3 
2.8/2.7 
2.6/2.8 
2.913.0 
3.013.0 
6.015.2 
4.8/6.5 
3.7/3.4 
3.313.4 
3.3/2.7 
3.0/2.9 
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Figure Legends 
Fig. 1. Overview of the R-like AMP/product complex of Leu54 FBPase. The four 
subunits of the tetramer, labeled C 1 through C4, are depicted with one molecule each 
of bound AMP (allosteric pocket) and F6P (active site). Active-site bound Pi and 
Mg2+ and side chains ofLeu54 from subunits Cl and C3 are omitted for clarity. 
Residues 52-72 (dynamic loop) and 187-195 (loop 190) are in black. The panel to 
the right shows electron density covering the AMP molecule from an omit map 
contoured at a level of 1-cr with a cutoff radius of 1 A. This drawing was prepared 
with MOLSCIRPT (38). 
Fig. 2. Quaternary states of FBPase. Various quaternary states of FBPase differ by 
rotations of subunit pair C3-C4 relative to subunit pair C 1-C2. Superpositions of 
FBPase tetramers, using selected Ca atoms from subunit pair C l-C2, reveals 
significant displacements in Ca atoms of C3-C4 subunit pairs in instances or 
differing quaternary states. Depicted here are displacements in Ca carbons of~­
strands of the AMP domain of the subunit pairs C3-C4 in the IR complex (bold lines) 
relative to those of FBPase in the R-state (A) and h-state (B), and T-state (C). The 
magnitude and direction of subunit rotations that transform the IR-state into the three 
other quaternary states of FBPase is indicated. The Ca atoms listed in Table III are 
the basis for superposition of subunit pair C 1-C2. This drawing was prepared with 
MOLSCIRPT (38). 
Fig. 3. Tertiary conformational changes between R- and IR-states. Dotted lines represent 
selected donor-acceptor interactions of 3 .2 A or less. Solid green lines represent 
potential non-bonded contacts of 2.5 A or less. Panels A-C: Superposition of the IR-
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state subunit (red) onto each subunit of the R-state tetramer (black) reveals tertiary 
conformational changes induced by the binding of AMP and the resulting 3° subunit-
pair rotation. Hydrogen bonds (dotted red lines) involving the 6-amino group of 
AMP and a non-bonded contact (green line) with the side chain of Val 17 induce helix 
movement and shears hydrogen bonds between Thr14 and Asn35 (panel A), as well as 
Glu192 and Thr39 (panels A-C). In addition, the movement of helix Hl displaces Ile10 
from its R-state hydrophobic contacts (panels Band C). This drawing was prepared 
with MOLSCIRPT (38). Inset: Shown are regions of the tetramer (purple) and 
viewing directions (bold arrows) corresponding to panels A-C. The viewing 
direction for panel C is 45° inclined to the plane of the tetramer. 
Fig. 4. Tertiary conformational changes between T- and IR-states. Superposition of the 
IR-state subunit (red) onto each subunit of the T-state tetramer (black) reveals tertiary 
conformational changes induced by the 12° subunit-pair rotation. An additional 
translation of helix H2 along its axis is evident (panels A-C). The disengaged loop 
(residues 52-72) covers the hydrophobic surface exposed by the displacement of Ile10 
(panel C). Close contacts between loops 190 of subunits Cl and C4 and Glu192 and 
Lys42 (solid green lines) are relaxed by conformational changes. The conformational 
change in Glu192 re-establishes its hydrogen bond with Thr39 (panels A-C). Regions 
of FBPase depicted and viewing directions are as indicated in Fig. 3. This drawing 
was prepared with MOLSCIRPT (38). 
Fig. 5. Models of concerted and sequential conformational change. The subunits of the 
FBPase tetramer are simplified to helix H2 (rectangle) and loop 190 (oval). The 
viewing direction is down a molecular axis of twofold symmetry, with subunit Cl and 
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C2 above the plane (bold lines) and subunit C3 and C4 below the plane. In the 
concerted model (left) AMP molecules bind successively in any order to the subunits 
of tetramer, until the combined torque (represented by open arrows) on each subunit 
pair exceeds the energy barrier that separates the R- and T-states. The binding of at 
least two AMP molecules is necessary for the concerted conformational change. In 
the sequential model (right), the first molecule of AMP can bind to any subunit with 
equal affinity, causing the outward movement of helix H2 of only that subunit (filled 
arrow). If binding occurs at subunit Cl, interactions between subunit Cl and C4 are 
weakened. The second molecule of AMP binds to subunit C4, because less binding 
energy is spent in the movement of helix H2 in that subunit. The R- to T-state 
transition can occur in response to the binding of at least two molecules of AMP. For 
the sequential mechanism, transition to the T-state restores hydrogen bonds lost by 
the AMP-induced movements of helices H2 in the R-state. 
Fig. 6. Stereoview of the proposed role of Arg22 in cooperativity of AMP inhibition. The 
view is down a molecular twofold axis toward the center of the tetramer. The 
superposition of the IR-state subunit (bold lines) onto subunit Cl of the R-state (fine 
lines) represents possible relaxation events due to the binding of AMP to subunit C 1 
(top). AMP-induced conformational change in helix Hl would allow the formation 
of a hydrogen bond between Arg22 (subunit Cl) and backbone carbonyl 108 (subunit 
C4), and stack the side chains of Arg22 and Phe89 (subunit C4). A second 
superposition of an IR-state subunit (bold lines) onto subunit C4 of the R-state (fine 
lines) represents the relaxation of subunit C4 to the altered conformation of AMP-
bound subunit Cl (bottom). The proposed interaction involving Arg22 (subunit Cl) 
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carries over to the symmetry-related Arg22 (subunit C4). As a consequence, the AMP 
pocket of subunit C4 may adopt a conformation that approximates the AMP-bound 
conformation of subunit Cl, even in the absence of AMP. This drawing was prepared 
with MOLSCIRPT (38). 
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CHAPTER 3. MECHANISM OF DISPLACEMENT OF A CAT AL YTICALL Y 
ESSENTIAL LOOP FROM THE ACTIVE SITE OF FRUCTOSE-1,6-
BISPHOSPHATASE+ 
Abstract 
A paper to be submitted to The Journal of Biological Chemistry 
Cristina V. Iancu, Susmith Mukund, Jun-Yong Choe, Herbert J. Fromm, 
and Richard B. Honzatko 1 
AMP transforms fructose-1,6-bisphosphatase from its active R-state to its inactive T-state. 
During this quaternary transition, a catalytically essential loop (dynamic loop) leaves the 
active site (engaged conformation) and moves up to 36 A to its inactive (disengaged) 
conformation. The mechanism of loop displacement is revealed here by structures of 
Ile 10~ Asp fructose-1,6-bisphosphatase. AMP/Mg2+ and AMP/Zn2+ complexes of the Asp 10 
enzyme are in T-like conformations, but the latter complex provides the first example of an 
engaged dynamic loop in a T-like quaternary state. Hydrogen bonds between Thr39 and 
Glu192, disrupted by the binding of AMP to the R-state, reform in the T-like complexes of the 
Asp 10 enzyme. The reformation of these linkages may in part drive the R- to T-state 
transition. Moreover, hydrogen bonds between AMP molecules and the effector binding site 
decrease in length as helix H 1 moves toward the center of the tetramer and forces loop 190 
into contact with the dynamic loop from a neighboring subunit. Movement of the loop 
evidently triggers a conformational change in residues 264-274 that transfers an unfavorable 
nonbonded contact within the R-state subunit to the distal end of the engaged loop. This 
This work was supported in part by National Institutes of Health Research Grant NS 10546. 
+coordinates and structure factors (accession labels 2F3B, 2F3D and 2F3H) for the structures 
described in this paper have been deposited in the Protein Data Bank, Research Collaboratory 
for Structural Bioinformatics (RCSB). 
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unfavorable contact may be a significant driving force in displacing the dynamic loop from 
its engaged conformation. 
Introduction 
Fructose-1,6-bisphosphatase (D-fructose-1,6-bisphosphate 1-phosphohydrolase, EC 3 .1.3 .11; 
FBPase1) catalyzes the hydrolysis of fructose 1,6-bisphosphate (Fl6P2) to fructose 6-
phosphate (F6P) and inorganic phosphate (Pi) (1,2). FBPase controls a tightly regulated step 
of gluconeogenesis: AMP and fructose 2,6-bisphosphate (F26P2) bind to allosteric and active 
sites, respectively, and inhibit FBPase while simultaneously activating fructose-6-phosphate 
I-kinase in glycolysis (3,4). Physiological levels ofF26P2 are subject to control by glucagon 
and insulin ( 4,5). As F26P2 enhances the binding of AMP to FBPase by up to an order of 
magnitude ( 6), AMP should become a more potent inhibitor of FBPase in vivo as 
concentrations of F26P2 increase. AMP binds 28 A away from the nearest active site, 
inhibiting catalysis noncompetitively with respect to Fl 6P2. Yet, AMP is a competitive 
inhibitor of catalysis with respect to essential divalent cations (Mg2+, Mn2+, or Zn2+), all of 
which probably bind with the 1-phosphoryl group ofF16P2 (7-10). 
FBPase is a homotetramer [subunit Mr of 37,000 (11)] and exists in at least two 
distinct quaternary states called Rand T (12-13), as well as intermediate conformations 
which are R-like (IR-state) (14) and T-like (h-state) (15). For the wild-type enzyme, AMP 
induces the transition from the active R-state to the inactive T-state. Substrates or products 
in combination with metal cations stabilize the R-state conformation. The quaternary 
transition and the binding of AMP is linked in some way to the conformational state of a 
dynamic loop (residues 52-72). That loop has been observed in three conformations called 
engaged, disengaged, and disordered ( 16). AMP alone or with F26P2 stabilizes a disengaged 
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loop (16,17), whereas metals with products stabilize an engaged loop (10,18-20). In active 
forms of the enzyme, loop 52-72 probably cycles between its engaged and disordered 
conformations ( 16, 18). Fluorescence from a tryptophan reporter group at position 57 is 
consistent with the conformational states for loop 52-72, observed in crystal structures 
(21,22). Thus far, the engaged conformation of loop 52-72 has appeared only in R-state 
crystal structures, and the disengaged conformer only in T-state structures; however, 
disordered conformations of the dynamic loop have appeared in both the R- and T-states 
(14,18,19,23,24). Recently, AMP complexes of Ala54~ Leu FBPase appear in two crystal 
forms. One AMP complex is in an R-like conformation with an engaged dynamic loop, 
whereas the other is in the T-state with a disordered dynamic loop. Evidently, the R- to T-
state transition (and not the binding of AMP) displaces the dynamic loop from its engaged 
conformation, but by what mechanism? 
Ile 10~ Asp FBPase has wild-type catalytic properties and retains cooperativity in 
AMP inhibition, but exhibits significant residual activity (30-40% of maximal velocity) at 
concentrations of AMP sufficient to saturate allosteric binding sites (16). On the basis of 
structures presented here, the mutation of Ile10 to aspartate disrupts key packing interactions 
of the N-terminal segment in the R-state and of the disengaged loop in the T-state, and thus 
destabilizes the canonical R- and T-states relative to intermediate quaternary states of 
FBPase. In the presence of saturating AMP, different crystal forms of Asp 1° FBPase grow in 
the presence ofMg2+ and Zn2+. In the AMP•Mg2+ complex, the enzyme is in its T-state with 
a disordered dynamic loop. In the AMP•Zn2+ complex, the tetramer is T-like with an 
engaged dynamic loop. The latter crystal form reveals tight contacts involving residues of 
the engaged loop that arise from the movement of loop 190 in the R- to T-state transition. 
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The quaternary transition triggers conformational change in residues 264-274 that transfers a 
tight contact from within the R-state subunit to the distal end of the dynamic loop. The 
transfer of an unfavorable contact from within the subunit to the dynamic loop may be a 
significant driving force in the quaternary transition. 
Experimental 
Materials-F16P2, F26P2, and AMP were purchased from Sigma. DNA-modifying and 
restriction enzymes, T4 polynucleotide kinase and ligase were from Promega. Glucose-6-
phophate dehydrogenase and phosphoglucose isomerase came from Roche. Other chemicals 
were of reagent grade or equivalent. Escherichia coli strains BMH 71-18 mutS and XL 1-
Blue came from Clontech and Stratagene, respectively. The FBPase-deficient E. coli strain 
DF 657 came from the Genetic Stock Center at Yale University. 
Mutagenesis of wild-type FBPase-The mutation oflle10 to aspartate was accomplished as 
described previously (16). The mutation and the integrity of the construct were confirmed by 
sequencing the promoter region and the entire open reading frame. The Iowa State 
University sequencing facility provided DNA sequences, using the fluorescent dye-dideoxy 
terminator method. 
Expression and Purification of As/° FBPase--Cell-free extracts of wild-type and Asp 10 
FBPase were subjected to heat treatment (63° C for 7 minutes), followed by centrifugation. 
The supernatant solution was loaded onto a Cibracon Blue sepharose column, previously 
equilibrated with 20 mM Tris-HCl, pH 7.5. The column was washed first with 20 mM Tris-
HCl, pH 7.5. Enzyme was eluted with a solution of 500 mM NaCl and 20 mM Tris-HCl of 
the same pH. After pressure concentration (Amicon PM-30 membrane) and dialysis against 
10 mM Tris-HCl, pH 8.0, the protein sample was loaded onto a DEAE sepharose column 
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equilibrated with 10 mM Tris-HCl, pH 8.0. Purified enzyme was eluted with a NaCl gradient 
(0-0.5 M) in 10 mM Tris-HCl, pH 8.0, and then dialyzed extensively against 50 mM Hepes, 
pH 7.4. Purity and protein concentrations of FBPase preparations were confirmed by SDS-
polyacrylamide gel electrophoresis (25) and the Bradford assay (26), respectively. 
Crystallization of the product complex-Crystals of Asp1° FBPase were grown by the 
method of hanging drops. Equal parts of a protein solution and a precipitant solution were 
combined in a droplet of 4 µL total volume. Wells contained 500 µL of the precipitant 
solution. R-state crystals grew from a protein solution [Asp1° FBPase (10 mg/ml), Hepes (25 
mM, pH 7.4), MgCh (5 mM), and Fl6P2 (5 mM)] combined with a precipitant solution 
[Hepes (100 mM, pH 7.4), polyethylene glycol 3350 (8% (w/v)), glycerol (27% (v/v)), and t-
butanol (5% (v/v))]. Crystals of the T-like AMP complex grew from a protein solution 
[Asp1° FBPase (10 mg/ml), Hepes (25 mM, pH 7.4), ZnCh (5 mM), Fl6P2 (5 mM), and 
AMP (5mM)] combined with a precipitant solution [Hepes (100 mM, pH 7.4), polyethylene 
glycol 3350 (12% (w/v)), glycerol (23% (v/v)), and t-butanol (5% (v/v))]. Crystals of the T-
state AMP complex grew from a protein solution [Asp 1° FBPase (10 mg/ml), Hepes (25 mM, 
pH 7.4), MgCh (5 mM), Fl6P2 (5 mM), and AMP (5 mM)] combined with a precipitant 
solution [Hepes (100 mM, pH 7.4), polyethylene glycol 3350 (14% (w/v)), 2-methyl-2,4-
pentanediol (21 % (v/v)), and t-butanol (5% (v/v))]. Crystals were of equal dimensions (0.2-
0.4 mm), growing in approximately three days at 20 °C. Conditions of crystallization include 
cryoprotectants, allowing crystals to be transferred directly from droplet to liquid nitrogen. 
Data collection-Data were collected at Brookhaven National Laboratory on beamlines 
X4A (R- and IT-state structures) and Xl2C (T-state structure) at a temperature of 110 K. 
Data were reduced with the program HKL (27). 
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Structure determination, model building and refinement- Crystals of Asp 1° FBPase are 
isomorphous to either the AMP/Zn2+/product complex (18) or the Zn2+/product complex (10). 
Phase angles, used in the generation of initial electron density maps, were based on model 
lEYJ or lCNQ of the PDB, from which water molecules, metal cations, small-molecule 
ligands, and residues 52-72 had been omitted. Residues 52-72 were built into the electron 
density of omit maps, using the program XT AL VIEW (28). Ligands were added to account 
for omit electron density at the active site and/or the AMP site. The resulting models 
underwent refinement, using CNS (29) with force constants and parameters of 
stereochemistry from Engh & Huber (30). A cycle of refinement consisted of slow cooling 
from 1000-300 K in steps of 25 K, followed by 120 cycles of conjugate gradient 
minimization, and concluded by the refinement of individual thermal parameters. Thermal 
parameter refinement employed restraints of 1.5 A 2 on nearest neighbor and next-to-nearest 
neighbor main chain atoms, 2.0 A.2 on nearest neighbor side chain atoms, and 2.5 A.2 on next-
to-nearest neighbor side chain atoms. 
In subsequent cycles of refinement, water molecules were fit to difference electron 
density of 2.5cr or better and were added until no significant decrease was evident in the Rfree 
value. Water molecules in the final models make suitable donor-acceptor distances to each 
other and the protein and have thermal parameters under 60 A 2. Stereochemistry of the 
models was examined by the use of PROCHECK (31 ). 
Results 
Rationale for the Ile10~ Asp mutation-The side chain of Ile10 packs against hydrophobic 
residues from loop 190 in the R-state, and against hydrophobic residues of the dynamic loop 
in its disengaged conformation of the canonical T-state. (Figures of Ile10 and nearby residues 
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are in references 14 and 16). The Ile 10~ Asp mutation introduces an electrostatic charge in 
local structures that cannot accommodate that charge. The R- and T-state hydrophobic 
clusters, however, are not present in the R-like AMP complex (14), and are probably not 
present in other intermediate quaternary states of the tetramer. Hence, Ile 10~ Asp should 
destabilize the canonical R- and T-states ofFBPase, with little or no effect on intermediate 
quaternary states. Furthermore, as Zn2+ (relative to Mg2+) stabilizes the engaged 
conformation of the dynamic loop by fully occupying metal site-3 of the active site (10,18), 
the AMP•product•Zn2+ complex of Asp 1° FBPase offers a reasonable opportunity to capture 
an intermediate quaternary state of FBPase with an engaged dynamic loop. 
Expression and purification of Asp10 FBPase-- Expression and isolation procedures 
described above provide Asp1° FBPase in at least 95% purity, as judged by SDS-
polyacryamide gel electrophoresis (data not shown). Gels indicated no proteolysis of the 
purified enzyme. 
Product complex of As/° FBPase (PDB identifier 2F3B)-Crystals belong to the space 
group 1222 (a=52.94, b=82.50 and c=l65.0 A), and are isomorphous to those of wild-type 
FBPase in its R-state, containing one subunit of the tetramer in the asymmetric unit of the 
crystal (10, 18-20). Electron density for residues 1-9 is weak or absent; the model begins at 
residue 10 and continues to the last residue of the sequence. Thermal parameters vary from 
11 to 55 A 2• The model has stereochemistry comparable to that of structures of equivalent 
resolution (31 ). Statistics for data collection and refinement are in TABLE ONE 
The product complex of Asp1° FBPase has one molecule each ofF6P and Pi bound to 
the active site with three atoms of Zn2+. The dynamic loop (residues 52-72) is in its engaged 
conformation. We refer the reader to other descriptions ofR-state product complexes 
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(10, 18-20) for more detailed descriptions of active site interactions. 
Superposition of the Asp 10 tetramer onto canonical wild-type R- and T-states clearly 
indicates an R-state complex. Superposition of the Asp 10 subunit onto the wild-type R-state 
subunit, however, reveals deviations in the relative positions of Ca atoms in excess of 0.5 A 
for residues 10-19 (FIGURE 1). Asp 10 has dissociated from the hydrophobic surface against 
which Ile 10 packs in the R-state of the wild-type tetramer, confirming the anticipated effect of 
the mutation. Helix Hl shifts essentially as a rigid body, and its movement perturbs the 
connecting element between helices H 1 and H2 that contains several residues critical to the 
recognition of AMP. The mutation oflle10 to aspartate and the binding of AMP to Leu54 
FBPase (14) have comparable effects on helix Hl and the conformation of its N-terminal 
segment. 
AMP/product T-like complex of Asp1° FBPase (PDB identifier 2F3D)-Crystals belong to 
the space group 1222 (a=55.84, b=82.50 and c=165.0 A). They contain one subunit in the 
asymmetric unit and are isomorphous to those of wild-type FBPase in its R-state (10,18-20). 
Electron density for residues 1-9 is weak or absent; the model begins at residue 10 and 
continues to the last residue of the sequence. Thermal parameters vary from 9 to 59 A2. The 
stereochemistry of the model is comparable to that of structures of equivalent resolution (31 ). 
The subunit of the AMP/product complex of Asp1° FBPase has one molecule each of 
F6P and Pi with three atoms of Zn2+ at the active site (FIGURE 2). In addition, strong 
electron density is present in the allosteric inhibitor pocket, which represents a bound 
molecule of AMP. The dynamic loop (residues 52-72) adopts the engaged conformation. 
Superposition of the Asp 10 tetramer onto canonical wild-type R- and T-states reveals a 
change in quaternary state. Subunit pair Cl-C2 has rotated approximately 12° relative to 
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C3-C4. The subunit rotation lies near that of the h-state (12° rotation) as defined by the 
wild-type enzyme in its complex with the allosteric inhibitor OC252 (15). 
The superposition of the IR-state subunit of the AMP complex of Leu54 FBPase onto 
the subunits of the h-state tetramer of the AMP complex of Asp1° FBPase reveals tertiary 
conformational changes that accompany the 9° subunit-pair rotation from the IR- to h-states. 
For the most part, changes in the relative positions of Ca atoms are less that 0.2 A; however, 
shifts in the positions Ca atoms of 0.5-4.0 A define four symmetry-related bands, connecting 
the AMP binding sites of subunits Cl, C2, C3 , and C4 to the active sites of subunits C2, Cl , 
C4, and C3, respectively (FIGURE 2). Correlated shifts in the positions of atoms extend 
from the AMP molecule to helix Hl, from helix Hl to loop 190, and then across subunit 
boundaries to the dynamic loop. Residues 264-274 shift in a direction that roughly opposes 
the movements emanating from the AMP pocket and helix Hl. Unlike the immediate effects 
of AMP-binding to the R-state (disruption of buried hydrogen bonds across the Cl-C4 
interface (14)), the tertiary conformational changes due to the 9° rotation from the IR- to Ir-
states cross the C l-C2 interface and involve elements on the surface of the tetramer. 
AMP and helix Hl move through comparable displacements of0.5-1.0 A during the 
IR- to h-state transition (FIGURE 3a). Helix H2 (and helix H3 as well) do not move. 
Hydrogen bonds between the N-6 atom of AMP and backbone carbonyl 17 and Thr31 become 
shorter, being 2.8 and 3.2 A, respectively, in the R-like AMP complex of Leu54 FBPase and 
2.7 and 3.0 A, respectively, in the T-like AMP complex of Asp1° FBPase. Moreover, in the 
h-state structure, Thr39 reestablishes its hydrogen bond with Glu 192 of a neighboring subunit 
(Cl-C4 contact); this hydrogen bond was disrupted in the AMP complex ofLeu54 FBPase 
(14). The movement in helix Hl carries over to residues 194-197 ofloop 190, and from 
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these residues to residues 53-55 of the dynamic loop (FIGURE 3b). The entire dynamic loop 
shifts toward Arg313 by approximately 0.5 A. In contrast, residues 264-274 move in 
opposition to the general thrust of the dynamic loop; the combined movements of the 
dynamic loop and loop 264-274 generate tight contacts between the Arg313 and Thr66 
(FIGURE 3c). In the IR-state, the side chain of Arg313 hydrogen bonds with the backbone 
carbonyls ofresidues 66 and 274 (donor-acceptor distances of 2.8-2.9 A), and is in contact 
with the C{3 atom of Thr66 (distance of 3.6 A). In the h-state, however, the donor-acceptor 
contacts diminish to approximately 2.5 A, and the contact involving the C{3 atom of Thr66 
becomes approximately 2.9 A. In short, the transition from the IR- to Ir-state lessens the 
space for the engaged conformation of the dynamic loop. 
The movement in loop 264-274 is relatively large (up to 4 A), and results in the 
elimination of a tight internal contact between the backbone carbonyl group of residue 272 
and the backbone amide group ofresidue 314. In the IR-state (as well as the R-state), the 
contact distance is approximately 2.8 A. Although the contact distance is reasonable for a 
donor-acceptor pair with a good mutual orientation, the axis of the backbone carbonyl 272 is 
perpendicular to the plane of the peptide link between residues 313 and 314. Hence, an 
unfavorable contact exits between residues 272 and 314 in the IR-state, and a small rotation 
of the carbonyl group of residue 272 not only relieves this tight contact in the Ir-state 
(contact distance becomes 3.1 A), but also drives the observed motion ofloop 264-274 in the 
IR- to Ir-state transition. 
AMP/product T-state complex of Asp1° FBPase (PDB identifier 2F3H)-Crystals belong to 
the space group P2 1212 (a=60.28, b=l67.0 and c=79.06), and are isomorphous to those of 
AMP complexes ofFBPase (16,17). The subunit pair Cl-C2 is in the asymmetric unit of 
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this crystal form. Regions of weak or absent electron density include residues 1-9 and 
55-72. The model begins at residue 8 and continues to the last residue of the sequence, but 
segment 55-72 is unreliable, as evidenced by thermal parameters as high as 115 A2• The 
model has stereochemistry generally comparable to that of structures derived from data of 
comparable resolution (31 ). Statistics for data collection and refinement are in Table II. The 
enzyme in this crystal form is in the T-state (quaternary transition angle of 15°); however, 
unlike loop-disengaged AMP complexes of the wild-type enzyme, the dynamic loop in T-
state Asp1° FBPase is disordered. The active site retains F6P and Mg2+ bound with low 
occupancy to site 1. Conditions of crystallization of the T-state and h-state AMP complexes 
of Asp1° FBPase differ only in the type of metal ion, Mg2+ for the former and Zn2+ for the 
latter. As anticipated, the Ile 10~ Asp mutation has destabilized the disengaged conformation 
of the dynamic loop. 
Discussion 
Hybrid tetramers ofFBPase that have one functional AMP binding site in each half of 
the tetramer (for instance, subunits Cl and C4 of FIGURE 1) exhibit cooperative inhibition 
by AMP, whereas a hybrid PB Pase that forces two AMP molecules to the same half (subunits 
Cl and C2) does not show cooperative inhibition (32). A sequential model of allosteric 
regulation is consistent with cooperative and noncooperative mechanisms of AMP inhibition 
(14). By binding to its allosteric site, AMP promotes small conformational changes that 
disrupt intra- and inter-subunit hydrogen bonds in the R-state, but the dynamic loop retains 
its engaged conformation. Transition to the T-state restores specific hydrogen bonds (for 
instance, the Thr39 to Glu192 inter-subunit linkages) disrupted by the binding of AMP to the 
R-state tetramer, but the quaternary transition also displaces the dynamic loop from its 
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engaged conformation. A hybrid tetramer with a single binding site for AMP is inhibited at 
least 100-fold more weakly relative to the wild-type enzyme, and does not undergo a 
transition to the T-state (32). Hybrid tetramers with two or three functional allosteric sites 
are potently inhibited by AMP and undergo transitions to the T-state. Hence, the transition to 
the T-state is necessary for potent AMP inhibition. Moreover, some mechanism allows AMP 
molecules in neighboring subunits to completely inhibit catalysis from subunits without a 
functional allosteric site. 
The published model of allosteric regulation in FBPase explains cooperative and 
noncooperative modes of AMP inhibition (14). The work here provides a mechanism for the 
displacement of the dynamic loop due to tight contacts that "squeeze" the loop out of its 
engaged conformation (FIGURE 4). The proposed mechanism of loop displacement is 
concerted; however, the crystalline environment, which has a single subunit of FBPase as its 
symmetry-unique element, could only be consistent with a concerted model. In solution, 
AMP molecules bound to subunits Cl and C4 can drive the quaternary transition, and could 
displace dynamic loops from subunits C2 and C3 more effectively than from subunits C 1 and 
C4. Hence, a sequential model of loop displacement is possible, in which a T-like quaternary 
state with two bound AMP molecules and two functional active sites exists as an 
intermediate. Such an intermediate form ofFBPase, however, must be present at vanishingly 
small concentrations. Hybrid tetramers with two or three binding sites for AMP exhibit 
potent inhibition by kinetic mechanisms indistinguishable from those of the wild-type 
enzyme (32), suggesting such forms of FBPase cannot have engaged dynamic loops. Hence, 
the available structural and kinetics data favor a sequential mechanism of AMP 
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destabilization of the R-state followed by a concerted transition to a T-like conformation, 
during which all engaged dynamic loops are displaced in unison (FIGURE 4). 
Asp 1° FBPase differs from the wild-type enzyme most significantly by its partial 
inhibition at saturating levels of AMP. Nelson et al. ( 16) suggested that the substantial 
activity came from a T-state tetramer. Other mutations of FBPase have resulted in partial 
inhibition at saturating levels of AMP (33-35), and for these other instances investigators 
have also suggested an active T-state (36). Results here indicate activity from the Ir state, 
which allows the engaged conformation, albeit with conformational strain. If the dynamic 
loop cannot form the disengaged conformation due to mutation, then the free-energy levels of 
the Ir- and T-states may be nearly equal, resulting in substantial activity in the presence of 
saturating AMP. 
Leu54 FBPase responds differently to AMP than does the Asp10 enzyme. The 
mutation Ala54~ Leu disrupts the disengaged conformation of the dynamic loop, but 
resulting enzyme still exhibits complete inhibition by AMP (14). Interestingly, Leu54 
FBPase, even in its AMP-bound IR-state, lacks Mg2+ at metal site-3, whereas R-state Leu54 
FBPase has Mg2+ at metal site-3 in high occupancy. Complete inhibition by AMP in the case 
of Leu54 FBPase may arise then from the inability of the dynamic loop to stabilize metal 
coordination to metal site-3 in all quaternary states except the R-state. Quite likely then, 
ligand interactions (such as the binding of F26P2 to the active site) or mutations that 
eliminate the binding of metal activators to site-3 will result in the complete loss of catalytic 
activity in liver FBPases. 
The conformational change in residues 264-274 was noted in a comparison of R- and 
T-state structures, but dismissed as a possible response to different packing environments in 
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the two crystal forms ofFBPase (10). Crystals of the R-, IR-, and h-states of FBPase are 
quasi-isomorphous with a maximum change of approximately 5% coming in the b unit cell 
parameter. Differences in the conformation ofresidues 264-274 must be in response to the 
quaternary transition, even though these residues are at the surface of the tetramer, and far 
from the Cl-C4 interface. Loop 264-274 may act as a switch. In the R-state, the stress 
associated with the tight contact between the backbone carbonyl group of residue 272 and the 
backbone amide group of residue 314 is offset by intra-subunit hydrogen bonds involving the 
side chains of residues 264- 274. At some point in the quaternary transition, the stress 
associated with the tight contact worsens and exceeds the energy of intra-subunit hydrogen 
bonds, triggering an abrupt conformational change that crowds the engaged conformation of 
the dynamic loop. If the foregoing analysis is valid, then the removal ofR-state hydrogen 
bonds within residues 264-274 should trigger a conformational change and the loss of 
activity. Loop 264-.274 then may offer an attractive target in the development of drugs that 
limit gluconeogenesis. 
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TABLE ONE. Statistics of data collection and refinement for Asp1° FBPase. 
Crystalline complexa R-state Ir-state T-state 
Resolution limit (A) 1.80 1.83 2.7 
Number of measurements 784,010 707,677 380,196 
Number of unique reflections 31,968 40,278 31,820 
Completeness of data(%): 
Overall 93.7 94.7 93.1 
Last shell/resolution-range (A) 74.3/1.86-1.80 93.6/1.91-1.83 95.7 /2.85-2.7 
Rsym b 
Overall 0.062 0.055 0.167 
Last shell/resolution-range (A) 0.10/1.86-1.80 0.12/1.91-1.83 0.33/2.85-2. 7 
Number of reflections in 
30,433 32,827 18,448 
refinement 
Number of atoms 2,672 2,736 5,307 
Number of solvent sites 179 186 201 
Rfactorc 0.226 0.214 0.198 
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Rfree d 0.25 0.243 0.284 
Mean B (A2) overall/protein 23/22 25/24 40/40 
Mean B (A 2) for AMP 36 37/31 
Root mean square deviations (deg): 
Bond lengths (A) 0.005 0.005 0.006 
Bond angles 1.4 1.3 1.3 
Dihedral angles 22.9 22.7 23.1 
Improper angles 0.76 0.76 0.77 
TABLE ONE. Footnotes. 
a Unit cell lengths (a, b, c) in A for the R-, h- and T-state complexes are (52.94, 82.50, 
164.96), (55.84, 82.50, 165.02), and (60.28, 167.00, 79.06), respectively. Unit cell angles (a, 
~' y) are 90° for space groups 1222 and P21212. 
b Rsym = LjLi I Iu - <f.j> I /:Li:L/u, where i runs over multiple observations of the same intensity, 
and j runs over all crystallographically unique intensities. 
c Rractor = L II Fobs I - I Peale II /:L I Fobs 1, where I Fobs I> 0. 
ct Rfree based upon 10% of the data randomly culled and not used in the refinement. 
75 
Figure Legends 
FIGURE ONE. Conformational changes in the R-state structure of Asp10 FBPase. The 
side chain of Asp 10 projects into the solvent, away from the hydrophobic surface 
against which the side chain of Ile 10 packs. Conformational differences occur over 
helix Hl and the connecting element between helices Hl and H2. Black lines 
represent the R-state of the wild-type enzyme (RCSB lCNQ) and open lines represent 
R-state Asp 1° FBPase. This drawing was prepared with MOLSCIRPT (37). 
FIGURE TWO. Overview of the T-like AMP/product complex of Asp10 FBPase. The 
four subunits of the tetramer, labeled C 1 through C4, are depicted with one molecule 
each of bound AMP (left). Each active site has one molecule of Fru-6-P (labeled 
F6P) and Pi, and three atoms of Zn2+. Side chains of Asp 10 from subunits Cl and C3 
are omitted for clarity. Residues 10-25 (helix Hl, subunits Cl and C3), 187-195 
(loop 190, subunits Cl and C3), 52-72 (dynamic loop, subunits C2 and C4), and 264-
274 (subunits C2 and C4) are in bold black lines. Rotation of the tetramer in the top 
panel by 45° about the horizontal molecular twofold axis (right) show correlated 
shifts in coordinates from the allosteric pockets of subunits C 1 and C4 to the active 
sites of subunits C2 and C3, respectively. The IR-state subunits from Leu54 FBPase 
(red lines) are superimposed on the subunits of the h-state Asp 10 tetramer (black 
lines). Shown only are structural elements of the IR subunit, the Ca-atoms of which 
deviate from those of the h structure by more than 0.5 A. This drawing was prepared 
with MOLSCIRPT (37). 
FIGURE THREE. Stereoviews of tertiary conformational changes between the IR- and 
h-states. Dotted lines represent selected donor-acceptor interactions of 3 .2 A or less. 
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Double-headed arrows represent tight contacts less than 3 A. Superposition of the IR-
state subunit from the R-like AMP complex of Leu54 FBPase (red) onto each subunit 
of the T-like AMP complex of Asp1° FBPase (black) reveals tertiary conformational 
change induced by a 9° subunit-pair rotation. Top: Conformational changes at the 
AMP binding site. Middle: Correlated shift in the positions of residues from the N-
terminal side of helix H 1 to residues of loop 190 and then across a subunit interface to 
the hinge residues of the dynamic loop. Bottom: The shift in residue positions at the 
distal end of the dynamic loop are opposed by the movement of loop 264-274 and the 
side chain of Arg313 . This drawing was prepared with MOLSCIRPT (37). 
FIGURE FOUR. Model of concerted loop displacement due to the IR- to h-state 
transition. The subunits of the FBPase tetramer are simplified to helix H2 
(rectangles), loop 190 (ovals), and segments representing loops 52-72 (dynamic loop) 
and 264-274. The viewing direction is down a molecular axis of twofold symmetry, 
with subunit Cl and C2 above the plane (bold lines) and subunits C3 and C4 below 
the plane. AMP molecules (not shown) are bound in both states, and helices H2 have 
been drawn outward from the center of the tetramer, weakening C 1-C4/C2-C3 
contacts in the IR-state. Strong C 1-C4/C2-C3 contacts are restored by the transition 
to the h-state. In concert with that transition, tightening contacts between loop 190 
and the hinge end of the dynamic loop move the distal end of that loop toward Arg313 
and loop 264-274. In order to relax a tight intra-subunit contact, loop 264-274 
undergoes a conformational change, which further crowds the dynamic loop. Further 
rotation to the canonical T-state (additional 3°) displaces the loop from its engaged 
conformation. 
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FIGURE THREE 
Key of Contacts: 
C1 -C2 
C3-C4 
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1111111111 C 1-C4/C2-C3 strong 
C1-C4/C2-C3 weak 
* Loop 190 - Dynamic loop 
# Loop 264 - Dynamic loop 
IR-state: 
Dynamic loop C1 
Loop 264-27 4 C 1 
Loop 264-27 4 C4 
Dynamic loop C4 
Ir -state: 
FIGURE FOUR 
Dynamic loop C3 
Loop 264-27 4 C3 
Dynamic loop C2 
Loop 264-27 4 C2 
Dynamic loop C2 
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CHAPTER 4. GENERAL CONCLUSIONS 
Summary 
The results presented in this thesis have lead to a more solid understanding of the 
mechanistic details of the allosteric transition of porcine liver FBPase. Although the earlier 
studies done on this system gave a basis for structural change and a list of possible 
interactions, they did not provide a specific structural mechanism for the transition from R to 
T-state. The trapping of porcine liver FBPase in intermediate states by engineering point 
mutations has helped isolate conformational changes due to the binding of AMP in the Ala54 
mutant and conformational changes due to the subunit-pair rotation in the Asp 10 mutant. The 
result is a model whereby AMP sequentially destabilizes the R-state, whereupon transition to 
the T-state displaces an essential catalytic loop from all active sites of the tetramer in concert. 
A key contact in the R-like state could be an energy source for a spring-loaded mechanism of 
transition into the T-state. 
Such structural and mechanistic studies on allosteric enzyme systems are essential 
since they have the power to aid the potential development of highly potent inhibitors. An 
inhibitor at the newly identified contact site in Asp 10 might be more potent and also 
synergistic with the effects of AMP and F26P2 or possibly any other allosteric inhibitor. 
There is hence the potential for development of effective candidates as inhibitors of FBPase 
in the treatment of type II non-insulin dependant diabetes. 
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